Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fabiani E et al. - Rhe GSTP1-105Val allele was associated to an increased risk of MDS and to higher probability of overall survival in the low/intermediate-1 IPSS risk group. The GSTP1-Ile105Val polymorphism is likely to influence MDS risk and prognosis.


Today in Basic Science/Genetics...keeping you current

Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
BMC Cancer, 10/21/09

Breast cancer in the elderly: a histological assessment
Histopathology, 10/15/09

Serum calcium levels are elevated among women with untreated postmenopausal breast cancer
Cancer Causes and Control, 11/03/09

Today in Myeloproliferative Dz...keeping you current

Bortezomib: a new therapeutic option for POEMS syndrome
European Journal of Haematology, 10/13/09

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09

Prognostic molecular markers in myelodysplastic syndromes
Expert Review of Hematology, 10/22/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address